FDA Drops Age Limit for Neffy - Top-Institutions - MDSpire

FDA Drops Age Limit for Neffy

Needle-free epinephrine expands access for younger children meeting weight criteria

  • By

  • Kathryn Wighton

  • March 27, 2026

  • 2 min

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Allergy and Immunology
    • Pediatrics
    • Emergency Medicine

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Allergy and Immunology
    • Pediatrics

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Allergy and Immunology
    • Pediatrics

  • #4

    Children's Hospital of Philadelphia
    Children's Hospital of Philadelphia

    Philadelphia, PA

    Key Differentiators

    • Pediatric Allergy and Immunology

  • #5

    Stanford University
    Stanford University

    Stanford, CA

    Key Differentiators

    • Allergy and Immunology
    • Pediatrics

Original Source(s)

FDA Drops Age Limit for Neffy

  • by Kathryn Wighton

  • March 27, 2026

Related Content

Editorial: New advances in cardiac electrophysiology

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Clinical Spectrum, independent risk factors, and treatment outcomes of pediatric arrhythmias: a multicenter retrospective analysis in Xinjiang